Invalid Symbol

Stock Research for SLXP

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


SLXP Stock Chart & Research Data

The SLXP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SLXP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


SLXP Due diligence Resources & Stock Charts

The SLXP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SLXP Detailed Price Forecast - CNN Money CNN View SLXP Detailed Summary - Google Finance
Yahoo View SLXP Detailed Summary - Yahoo! Finance Zacks View SLXP Stock Research & Analysis -

Stock Analysis

TradeIdeas View SLXP Trends & Analysis - Trade-Ideas Barrons View SLXP Major Holders - Barrons
NASDAQ View SLXP Call Transcripts - NASDAQ Seeking View SLXP Breaking News & Analysis - Seeking Alpha
Spotlight View SLXP Annual Report - OTC Report View SLXP OTC Short Report -
TradeKing View SLXP Fundamentals - TradeKing Charts View SLXP SEC Filings - Bar Chart
WSJ View Historical Prices for SLXP - The WSJ Morningstar View Performance/Total Return for SLXP - Morningstar
MarketWatch View the Analyst Estimates for SLXP - MarketWatch CNBC View the Earnings History for SLXP - CNBC
StockMarketWatch View the SLXP Earnings - StockMarketWatch MacroAxis View SLXP Buy or Sell Recommendations - MacroAxis
Bullish View the SLXP Bullish Patterns - American Bulls Short Pains View SLXP Short Pain Metrics -

Social Media Mentions

StockTwits View SLXP Stock Mentions - StockTwits PennyStocks View SLXP Stock Mentions - PennyStockTweets
Twitter View SLXP Stock Mentions - Twitter Invest Hub View SLXP Investment Forum News - Investor Hub
Yahoo View SLXP Stock Mentions - Yahoo! Message Board Seeking Alpha View SLXP Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for SLXP - Insider Cow View Insider Transactions for SLXP - Insider Cow
CNBC View SLXP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SLXP - OTC Markets
Yahoo View Insider Transactions for SLXP - Yahoo! Finance NASDAQ View Institutional Holdings for SLXP - NASDAQ

Stock Charts

FinViz View SLXP Stock Insight & Charts - StockCharts View SLXP Investment Charts -
BarChart View SLXP Stock Overview & Charts - BarChart Trading View View SLXP User Generated Charts - Trading View

Latest Financial News for SLXP

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Salix Provides Update on FDA Submission for PLENVU®*
PR Newswire (press release) - Feb 9, 2018
BRIDGEWATER, N.J., Feb. 9, 2018 /PRNewswire/ -- Salix Pharmaceuticals, Ltd. ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned ...

Salix Pharmaceuticals Reports 4Q2014 and FY2014 Results
Business Wire (press release) - Mar 2, 2015
Salix Pharmaceuticals, Ltd., headquartered in Raleigh, North Carolina, develops and markets prescription pharmaceutical products and medical devices for the prevention and treatment of gastrointestinal diseases.

Why Salix Pharmaceuticals, Ltd. Stock Was Clobbered in November
Motley Fool - Dec 5, 2014
Salix's management has reduced 2014 sales estimates since this latest presentation. Source: Salix Pharmaceuticals. As icing on the cake, Salix's chief financial officer announced his resignation, and the board of directors' audit committee announced ...

Salix Pharmaceuticals Completes Acquisition of Santarus
Business Wire (press release) - Jan 2, 2014
RALEIGH, N.C.--(BUSINESS WIRE)--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that it has completed its previously announced tender offer for all outstanding shares of common stock par value $0.0001 per share, including the associated ...
Salix Pharma Acquires Santarus -

Enter a stock symbol to view the stock details.